CRKL and neoplasm: The relationship between the tumor invasiveness and the expression of extracellular CrkL, including the fraction that binds to the PSI domain of β1 integrin on the membrane, as well as the soluble excreted fraction that is identified in the blood sera, can be related to the effect on tumor migration and proliferation caused by activation of the above pathways [19].